Frontlight ResearchEarly access
What researchers published on Myelodysplastic syndromes
912 papers, newest first.
Showing 40 of 912
Optimizing Reduced-Intensity Conditioning for Older Patients with AML and MDS: A Large-Scale Analysis from the CIBMTR.Blood
Aligning Clinical Trial Reporting: A systematic analysis and position statement by the International Consortium for MDS.Blood
Teclistamab in multiple myeloma with coexisting myelodysplastic syndrome or acute myeloid leukemia.Haematologica
Exploring neuropsychological alterations in VEXAS syndrome.Clinical and experimental medicine
Case reportMyelodysplastic Syndrome With Isolated del(5q) Coexisting With Cold Agglutinin Disease Presenting as Unexplained Hyperbilirubinemia.Cureus
Development and validation of a baseline interpretable prognostic model for mortality risk stratification in myelodysplastic syndrome patients receiving hypomethylating agent therapy.Current problems in cancer
MicroRNA dysregulation in mesenchymal stromal cells in myelodysplastic syndromes and its modulation by azacitidine and bortezomib.Leukemia & lymphoma
ReviewSGLT2 Inhibitors and Hemoglobin Improvement in Myelodysplastic Syndromes and Myeloproliferative Neoplasms: Mechanistic Rationale and Emerging Clinical Evidence.Anemia
Mesenchymal stromal cells drive immune escape in MDS and sAML through metabolic rewiring of NK cells.Leukemia
Integrating functional marrow reserve and molecular risk improves prediction of post-transplant outcomes in HMA-treated myelodysplastic syndromes.Blood neoplasia
PreprintPersistent Malignant Stem Cells Drive Relapse After Transplantation in the Myelodysplastic Neoplasms.bioRxiv : the preprint server for biology
Luspatercept in Myelodysplastic Syndromes With Ring Sideroblasts: Long Term Outcome and Impact on Non-Erythroid Blood Counts.Hematological oncology
Impact of Venetoclax Bridging on Haematopoietic Stem Cell Transplantation Outcomes in Advanced Myelodysplastic Neoplasms.Transplantation and cellular therapy
NUDT21 knockdown modulates alternative polyadenylation and promotes leukemic transformation in myelodysplastic syndromes.Neoplasma
Molecular and clinical profiling of SF3B1, U2AF1, and SRSF2 mutations in Iranian patients with myelodysplastic neoplasms.Molecular biology reports
Frontline isocitrate dehydrogenase inhibitor therapy in isocitrate dehydrogenase-mutated myelodysplastic neoplasms.Haematologica
Prevalence and prognostic implications of systemic autoinflammatory and autoimmune diseases in myelodysplastic neoplasms: a retrospective Belgian cohort study.Clinical and experimental medicine
GATA2 Deficiency Presenting With a WHIM-Like Phenotype and Subsequent Development of Monosomy 7-Associated Myelodysplastic Syndrome in an Adolescent Female: A Case Report.Clinical case reports
Review[Hematological features and advancement in the diagnosis of VEXAS syndrome].Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Willingness to Pay for Temporary Transfusion Independence in Lower-Risk Myelodysplastic Syndromes: Evidence from a Cross-Sectional Study in China.Patient preference and adherence
Complement deposition in the bone marrow of patients with myelodysplastic neoplasms.Signal transduction and targeted therapy
Can we better evaluate responses in higher-risk myelodysplastic syndromes?Haematologica
Infectious burden and cellular immune impairment in higher-risk myelodysplastic syndromes with biallelic TP53 alterations.Frontiers in cellular and infection microbiology
Review[Advances in the management of myelodysplastic neoplasms].[Rinsho ketsueki] The Japanese journal of clinical hematology
Case reportPearls & Oy-sters: Beyond the Bone Marrow-VEXAS Syndrome Presenting as Subacute Encephalomyelitis.Neurology
A Novel Insight Into Luspatercept: Therapeutic Implications in Myelodysplastic Syndrome Patients With Elevated Pulmonary Artery Systolic Pressure.Pulmonary circulation
IDH2 p.R172 mutation Predicts Superior Outcomes in IDH-mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome patients undergoing Allogeneic Hematopoietic Cell Transplantation: a retrospective study from the Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH-TC).Transplantation and cellular therapy
Comparison of Fludarabine/Treosulfan Conditioning with Melphalan-Based Sequential Conditioning in Patients with MDS and Increased Blasts Undergoing Upfront Transplantation.Cancers
ReviewDiagnostic and Clinical Considerations in Myeloid Neoplasms with del(5q): Distinguishing Myelodysplastic Neoplasm with Low Blasts and del(5q) from Myeloid Neoplasms with del(5q) Post-Cytotoxic Therapy.Genes
Correction: Balaian et al. Systemic Metabolic Changes in Plasma of Patients with Myelodysplastic Neoplasms and Chronic Myelomonocytic Leukemia. Metabolites 2026, 16, 648.Metabolites
Inflammasome activation promotes the progression of myelodysplastic syndrome.Experimental hematology
Post-transplant monitoring of NGS-based measurable residual disease and donor chimerism as a prognostic tool in older patients with AML/MDS.Blood research
ReviewClinical applications of CD34+ progenitor cell immunophenotyping in myelodysplastic neoplasms-The CytHem SMD French network experience.Cytometry. Part B, Clinical cytometry
PreprintMulti-hit STAG2 mutations define a high-risk subset of MDS and reveal convergent evolutionary targeting of cohesin.bioRxiv : the preprint server for biology
From ribosomal stress to clonal adaptation: Del(5q) MDS as a paradigmatic acquired ribosomopathy.Seminars in hematology
Patient-derived neomorphic SEPTIN6 mutations induce hematopoietic stem cell senescence underlying congenital neutropenia and myelodysplasia.JCI insight
A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome.Clinical immunology (Orlando, Fla.)
A comparison of overall survival and quality of life in patients with MDS treated with azacytidine vs decitabine.Blood neoplasia
Venetoclax plus hypomethylating agent improves response rates but not survival in TP53-mutated myelodysplastic syndromes.Blood neoplasia
Case reportA rare case of acute basophilic leukemia transformed from high risk myelodysplastic syndrome.Annals of hematology